Navigation Links
DTX 880 Multimode Detector

ProductsDTX 880 Multimode Detector
Company Beckman Coulter, Inc.
Item DTX 880 Multimode Detector
Features Inquire
Description The DTX Series Multimode Detectors provide unmatched value and flexibility for a variety of application and automation needs. Capable of performing fluorescence, luminescence and absorbance measurements on the same instrument, the DTX Series can operate as standalone instruments or can be integrated seamlessly with Beckman Coulters Biomek Laboratory Automation Workstations. The DTX Series is ideal for a broad range of Systems Biology applications, including drug discovery, genomics, proteomics and cell-based research. The unique optics design (patents pending) ensures precise performance and sensitivity across all detection modes. The instruments facilitate easy integration with automated liquid handling systems via a choice of plate loading options. These include an extra-wide plate access door, and the ability to accept plates in portrait or landscape formats. In addition, the detectors intuitive software platform provides instrument control and easy protocol development, as well as compatibility with Beckman Coulters Biomek software program.

The DTX 880 features fluorescence intensity (top and bottom reading), time-resolved fluorescence, fluorescence polarization, absorbance (UV and visible), glow luminescence and temperature control for 6-384-well plates. In addition, the instrument also features linear and orbital shaking, plus temperature control. Users can program endpoint, kinetic, multiple wavelength, linear scan and area scan measurement types. Easily accessible six-position filter slides enable wavelength selection from 230nm to 750nm.

Info Beckman Coulter, Inc.
Customer Service: (800) 742-2345
Web site: http://www.beckmancoulter.com

Related medicine products :

1. Multimode reader
2. DTX 800 Multimode Detector
3. SA-1000 Air Detector/Clamp
4. H-30 Air Detector Clamp
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 2BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in China's National Insurance Catalog 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 1Nations Oldest Taxpayer Group Criticizes Committee Vote for Baucus Health Bill Hidden Tax Increases 59401 2Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 1Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 2Fraunhofer CSE Opens First Laboratory in Cambridge MA 14456 3Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 1Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 2Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 3Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 4Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations 14454 5